About Precision BioSciences
Precision BioSciences (NASDAQ:DTIL) is a biotechnology firm dedicated to improving lives through its proprietary genome editing platform, ARCUS. This innovative company is engaged in the development of novel therapeutics and solutions in the field of gene editing, with a keen focus on overcoming cancer and genetic diseases. Precision BioSciences is actively working on a range of projects including but not limited to, next-generation CAR T-cell therapies aimed at addressing unmet medical needs in oncology, and gene therapies to tackle rare genetic disorders. The company's objectives are rooted in leveraging its cutting-edge technology to create precise, targeted treatments that offer a significant advantage over existing therapies, ultimately striving to deliver revolutionary medical breakthroughs and improve patient outcomes.
Snapshot
Operations
Produtos e/ou serviços de Precision BioSciences
- ARCUS gene editing platform, a technology for precise gene editing in healthcare, agriculture, and manufacturing.
- PBCAR0191, an allogeneic CAR T therapy targeting CD19 for B-cell malignancies.
- PBCAR20A, an off-the-shelf CAR T therapy aimed at treating Non-Hodgkin Lymphoma and other B-cell malignancies.
- PBCAR269A, designed for multiple myeloma treatment, leveraging an allogeneic CAR T approach.
- In Vivo Gene Correction using ARCUS for genetic diseases, focusing on liver-directed therapies.
- Allogeneic CAR T Cell Therapies for solid tumors, expanding the potential applications of their gene editing technology.
equipe executiva do Precision BioSciences
- Mr. Michael AmorosoPresident, CEO & Director
- Dr. Jefferson J. Smith Ph.D.Co-Founder & Chief Research Officer
- Mr. John Alexander Kelly R.Ph.CFO & Principal Accounting Officer
- Dr. Cassie Gorsuch Ph.D.Chief Scientific Officer
- Mr. Naresh TannaChief of Staff to CEO & Head of Investor Relations
- Mr. Dario Scimeca J.D.General Counsel & Secretary
- Ms. Juli BlancheChief People Officer
- Ms. Cindy AtwellChief Development & Business Officer
- Mr. Neil Leatherbury M.S.Senior VP and Head of Chemistry, Manufacturing & Controls